Naturally inspired.
Engineered to deliver.

Transformative exosome therapeutics

About Us

We are committed to transforming the treatment landscape for severe neurological and neurodegenerative diseases, addressing critical areas of unmet medical need. By advancing innovative therapeutics through our proprietary ExoEditTM technology, we aim to unlock new therapeutic options and positively impact the lives of patients and their families.

Read More

Pipeline

Evox is developing a proprietary pipeline of potentially transformative therapies for treating life-threatening neurological and neurodegenerative diseases.

Partners

At Evox, we see strategic partnerships as playing a key role in advancing innovative medicines for patients in need and we are always interested in speaking to organisations that share our goal of addressing the root cause of rare neurodegenerative and neurological diseases.

Technology Many diseases of the central nervous system are driven or influenced by the genetic makeup of the cells of the human brain. Evox uses a proprietary CRISPR/Cas-based gene editing system encapsulated inside an exosome-based nanoparticle to knock-down the genes responsible for neurodegenerative and neurological diseases.

Our Science

Evox Therapeutics is advancing a transformative approach to treating neurological and neurodegenerative diseases by combining state-of-the-art genome editing technologies with the natural biological capabilities of exosomes.
Read More

Latest News

Publication of a paper in Nature Biomedical Engineering highlights improved delivery and efficacy of therapeutics using Evox Therapeutics’ targeted exosomes

May 20, 2024